Predictors of sustained response to alpha interferon therapy in chronic hepatitis C
- 1 October 1999
- journal article
- clinical trial
- Published by Elsevier in Clinical Biochemistry
- Vol. 32 (7) , 537-545
- https://doi.org/10.1016/s0009-9120(99)00053-3
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999Journal of Hepatology, 1999
- Reduced plasma transforming growth factor-β1 levels in patients with chronic hepatitis C after interferon-α therapy: association with regression of hepatic fibrosisJournal of Hepatology, 1999
- Cytokines and the liverJournal of Hepatology, 1997
- Biological properties of interleukin‐12 and its therapeutic use in persistent hepatitis B virus and hepatitis C virus infectionJournal of Viral Hepatitis, 1997
- Recombinant interferon‐α‐2a for treatment of chronic hepatitis C: results of a multicenter randomized controlled dose studyLiver International, 1997
- Effect of r-interferon alpha administration on hypothalamus-pituitary-thyroid axis in chronic hepatitisLife Sciences, 1996
- Liver‐infiltrating and circulating CD4+ T cells in chronic hepatitis C: immunodominant epitopes, HLA‐restriction and functional significanceLiver International, 1996
- Monokine production by peripheral whole blood in chronic hepatitis C patients treated with interferonDigestive Diseases and Sciences, 1995
- Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-αDigestive Diseases and Sciences, 1994
- Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patientsHepatology, 1991